Connect with us

Health & Wellness

New Funding to Improve Food Systems Will Help Prevent Zoonotic Diseases

Published

on

Germany became the first donor today to invest in Food Systems 2030, a new World Bank Multi-Donor Trust Fund that proposes to help countries maximize the impact of their public spending and transform their food systems to increase food security and reach their 2030 Sustainable Development Goals. The German Federal Ministry of Economic Cooperation and Development (BMZ) announced over US$ 17 million (15 million euros) to contribute to the creation of foundations for sustainable food systems that deliver improved livelihoods and safe, affordable and nutritious diets for all.

This catalytic financing will promote new agriculture and food models that simultaneously improve the health of people, planet, and economies. It comes at a time when the COVID-19 pandemic has highlighted the massive cost of zoonotic diseases emerging in natural environments destabilized by human activity and spreading from animals to humans. Measures taken to slow the pandemic have also tested the strength of food supply chains that provide millions of jobs and keep rural and urban areas stocked in safe, affordable and nutritious food. COVID-19 has also stressed the importance of healthy diets for people’s immunity and resilience in the face of disease.  

Germany announced its contribution as part of a broader investment in healthier food systems and pandemic prevention.  “Even if the situation is dramatic – COVID-19 will not be the last pandemic. One lesson from this must be that the international community has to work together better to prevent future pandemics,” said Dr Gerd Müller, Federal Minister for Economic Cooperation and Development, Germany. “To that end, we have to improve the mutual integration of our projects in the field of One Health and launch new initiatives – on human and animal health, on access to safe drinking water, on the protection of biodiversity, and on healthy food. By contributing to the Food Systems 2030 fund, we are giving a targeted boost to food safety and to the early detection of zoonoses in food production.”

The One Health approach explicitly recognizes the interlinkage of human health, animal health, and the health of ecosystems. Over 70 percent of emerging infectious diseases affecting humans have their origins in animals, including COVID-19. The livestock sector is also responsible for about 73 percent of all antibiotic consumption, increasing the risk of deadly antimicrobial resistance which may further compromise human health in the future.

“We welcome Germany’s commitment to help countries rethink the way they manage agriculture and food to mitigate risks and generate better development outcomes,” said Martien Van Nieuwkoop, Global Director of the Agriculture and Food Global Practice at the World Bank. “Learning from best practices and drawing on innovative approaches, there is tremendous scope to modernize the policies and practices that govern agriculture and food, and help countries address the pervasive challenges of rural poverty, environmental degradation, and illnesses connected to unsafe practices and poor diets.”

Food Systems 2030 seeks to leverage public financing, private sector investments and consumer spending towards food systems transformation. It will provide policy advice and analytical products to country partners, steer World Bank lending and engage with the private sector in pursuit of one goal: achieving a food system that delivers healthy people, a healthy planet and healthy economies. It will promote new ways of doing business while addressing market and institutional incentives, to put food systems on a better path. To achieve its objectives, Food Systems 2030 will support integrated activities along nine pathways: better diets; prevention of zoonotic diseases; improved food safety; reduction in GHGs; reduction in pollution; improved land, water and food loss and waste management; promotion of productivity growth; increased job creation; maintaining trade flows.

Continue Reading
Comments

Health & Wellness

COVID-19: WHO expresses hope worst of Omicron wave is over

Published

on

Omicron continues to sweep the world, but cases seem to have peaked in some countries, which gives the head of the World Health Organization (WHO) hope that the worst of this latest wave of COVID-19 is over. 

Briefing journalists in Geneva, Tedros Ghebreyesus said that more than 18 million cases were reported last week, and the pandemic itself is far from over, so no country is out of the woods yet.

The number of deaths remains stable, but the agency is concerned about the impact the variant is having on already exhausted health workers and overburdened health systems.

“I remain particularly concerned about many countries that have low vaccination rates, as people are many times more at risk of severe illness and death if they’re unvaccinated”, Tedros said. 

Omicron may be less severe, but for the WHO chief “the narrative that it is mild disease is misleading, hurts the overall response and costs more lives.”

Tedros noted that the virus is circulating “far too intensely with many still vulnerable” and argued that, for many countries, the next few weeks remain critical.

COVAX

Over the weekend, the UN-backed COVAX facility delivered its one-billionth dose of vaccine. 

Tedros said he was proud of the milestone, but believes it’s essential to keep forging ahead with distributing shots fairly, across the world. 

“Vaccines may be less effective at preventing infection and transmission of Omicron than they were for previous variants, but they still are exceptionally good at preventing serious disease and death”, he explained. 

For him, immunization continues to be “key to protecting hospitals from becoming overwhelmed.”

Tracking the virus

The WHO chief also highlighted the importance of tracking new variants, like Omicron, in real time.

Tedros believes that the pandemic is “nowhere near over” and, with the incredible growth of Omicron, new variants are likely to emerge

So far, more than 7 million whole genome sequences from 180 countries have been submitted to GISAID, a global mechanism that provides open access to genomic data and was initially set up to track flu.

Using all that data, new formulations of vaccines are being developed and assessed for how they perform against different strains. 

Despite those efforts, Tedros is concerned that the world will enter “a second and even more destructive phase of vaccine inequity”, if it doesn’t change course. 

New treatments 

Last Friday, WHO recommended two new COVID-19 treatmentsto fight severe illness and death: a rheumatoid arthritis drug called baricitinib and a monoclonal antibody called sotrovimab.

For Tedros, the challenge, once again, is that high prices and limited supply means access is limited.

WHO is currently working with its partners in ACT-Accelerator to negotiate lower prices with manufacturers and ensure supply will be available for low- and middle-income countries.

Meeting

Next week, the WHO Executive Board, which is made up of 34 Member States, will meet to discuss the world’s health challenges.

The pandemic will remain at the forefront, but Member States will also be discussing the devastating impact of the pandemic on other health issues, and how the backsliding can be stopped. 

According to the WHO chief, the agency willbe working to accelerate progress on negotiations around a global pandemic accord.

Cervical Cancer Awareness

On a final note, Tedros noted that January is Cervical Cancer Awareness month.

In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide and about 342, 000 women died from the disease.

The main cause of the disease is infection with high-risk types of human papillomavirus (HPV), an extremely common family of viruses that are transmitted through sexual contact.

There are, however, vaccines that protect against high-risk HPV types, which means it should be one of the most preventable and treatable forms of cancer.

On Monday, Serbia announced that this year,it will introduce a vaccination programme against HPV, joining the 116 nationswho already do it. 

Continue Reading

Health & Wellness

UN-backed COVAX mechanism delivers its 1 billionth COVID-19 vaccine dose

Published

on

photo © UNICEF/Aimable Twiringiyima

With a 1.1 million jab delivery in Rwanda this weekend, the World Health Organization’s multilateral initiative to provide equal access to vaccines for all reached the one billion milestone.

Along with the Coalition for Epidemic Preparedness Innovations (CEPI), the Vaccine Alliance GAVI, and partners, WHO has led the largest vaccine procurement and supply operation in history with deliveries to 144 countries to date.

According to a press release published on Sunday, as of 13 January 2022, out of 194 countries members of WHO, 36 have vaccinated less than 10% of their population, and 88 less than 40%.

COVAX’s ambition was compromised by hoarding/stockpiling in rich countries, catastrophic outbreaks leading to borders and supply being locked. And a lack of sharing of licenses, technology, and know-how by pharmaceutical companies meant manufacturing capacity went unused”, the agency explained.

On 24 February 2021, Ghana became the first country in the world to receive vaccines through COVAX when 600,000 doses of the Oxford–AstraZeneca vaccine were delivered to Accra. 

The work that remains

COVAX is currently working with governments, manufacturers and partners to ensure that when countries receive vaccines, they can get them to people quickly.

“The work that has gone into this (1 billion) milestone is only a reminder of the work that remains”, the UN’s health agency underscored.

They added that with updated vaccines in the pipeline, citizens should demand that governments and pharmaceutical companies share health tools globally and “bring an end to the death and destruction cycles of this pandemic, limit new variants and drive a global economic recovery”.

COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched by WHO in April 2020 in response to the pandemic.

The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. 

Continue Reading

Health & Wellness

WHO recommends two new drugs to treat patients with COVID-19 

Published

on

Around two million doses of Sotrovimab are being produced globally in the first half of 2022. © GlaxoSmithKline

The World Health Organization (WHO) on Thursday reccommended two new drugs to treat patients with COVID-19, one for patients with critical disease, and another deemed effective for non-severe cases.

The first drug, baricitinib, is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.

According to the WHO Guideline Development Group, it is “strongly recommended” for patients with severe or critical disease in combination with corticosteroids.

The group of international experts based their recommendation on “moderate certainty evidence” that it improves survival and reduces the need for ventilation.

There was no observed increase in adverse effects.

The experts note that it has a similar effectas other arthritis drugs called interleukin-6 (IL-6) inhibitors. Because of that, when both drugs are available, they suggest choosing the best option based on cost, availability, and clinician experience.

It is not recommended to use both drugs at the same time.

The experts also advise against the use of two other JAK inhibitors (ruxolitinib and tofacitinib) for patients with severe or critical cases of COVID-19 infection.

According to them, trials undergone using these drugs failed to show any benefits arising using either drug,and suggested a possible increase in serious side effects with tofacitinib.

Non-severe cases

In the same update, WHO makes a conditional recommendation for the use of a monoclonal antibody known as sotrovimab in patients with non-severe cases.

According to them, the drug should only be administered to patients at the highest risk of hospitalisation. In those at lower risk, it onlyshowed “trivial benefits”. 

A similar recommendation has been madepreviously, for another monoclonal antibody drug, casirivimab-imdevimab, and the experts say there is insufficient data to recommend one over the other.

For both, the effectiveness against new variants, like Omicron, is still uncertain. 

The group will update their guidelines for monoclonal antibodies when more data becomes available.

Recommendations

These recommendations are based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical infections.

Developed by WHO with the methodological support of MAGIC Evidence Ecosystem Foundation, the guidelinesprovide trustworthy guidance and help doctors make better decisions with their patients.

According to the agency, the guidelines are useful in fast moving research areas, because they allow researchers to update evidence summaries as new information becomes available.

The latest guidance also updates recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical COVID-19; conditional recommendations for the use of casirivimab-imdevimab (another monoclonal antibody treatment) in selected patients; and against the use of convalescent plasma, ivermectin and hydroxychloroquine, regardless of disease severity.

Continue Reading

Publications

Latest

Eastern Europe6 hours ago

Ukraine Lies About 2022 Russian Attack to Hide Dying Economy

Yesterday, Ukraine’s president Zelensky speaking to the Ukrainian Foreign Intelligence Service said “We have learned to contain external threats. It...

Reports13 hours ago

Structural Reforms Needed to Put Tunisia on Path to Sustainable Growth

Decisive structural reforms and an improved business climate are essential to put Tunisia’s economy on a more sustainable path, create...

Development15 hours ago

‘Global learning crisis’ continues says Guterres; millions still hit

Almost two years into the COVID-19 pandemic, school closures continue to disrupt the lives of over 31 million students, exacerbating what...

Middle East18 hours ago

Ukraine crisis could produce an unexpected winner: Iran

 Iran potentially could emerge as an unintended winner in the escalating crisis over Ukraine. That is, if Russian troops cross...

Finance18 hours ago

How Twitter can help your business

Twitter is easily one of the leading online platforms which encourages networking on a global scale. The number of users,...

Economy20 hours ago

2022: Rise of Economic Power of Small Medium Businesses across the World

Why mirrors of the Wall: To fight obesity a life-sized mirror required, to uplift the national economy a simple calculator is...

Reports22 hours ago

Lebanon’s Crisis: Great Denial in the Deliberate Depression

The scale and scope of Lebanon’s deliberate depression are leading to the disintegration of key pillars of Lebanon’s post-civil war...

Trending